Arthrex
Device Knee & Hip - Implants - Hip - Fibertak
PDI 00888867362888
General payments
$23,928,055
Research payments
$288,494
Through program year 2025, $23,928,055 in general payments and $288,494 in research payments were reported against Arthrex (Hip - Fibertak).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $8,400 | 1 |
| 2025 | Research | $116,521 | 19 |
| 2024 | General | $13,435,746 | 39 |
| 2024 | Research | $142,874 | 26 |
| 2023 | General | $10,483,910 | 52 |
| 2023 | Research | $29,100 | 7 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
92 general · 52 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.